N ormal pregnancy, in the human as well as in the rat, is characterized by lowered blood pressure and attenuated responses to vasoactive agents. [1] [2] [3] These vascular changes are widely assumed to be endothelium-dependent. 2, 4 Pregnancy-induced hypertension, on the other hand, is associated with enhanced vascular reactivity and endothelial dysfunction 5 assumed to be the result of failure of maternal vascular adaptations. However, the etiological factor for maternal vascular adaptation in normal pregnancy and its failure in pregnancy-induced hypertension remains unknown. Identification of such a factor might advance the understanding of the pathophysiology of pregnancy-induced hypertension and lead to more effective and rational management of the condition. We have previously reported that plasma from normal pregnant women attenuated the reactivity of isolated vascular smooth muscle, 6 suggesting that a blood-borne agent might be responsible for depressed vascular reactivity in normal pregnancy.
Human chorionic gonadotrophin (hCG) is produced in vast quantities in normal human pregnancy, but its specific functions remain largely unknown. There are reports that administration of hCG to women for ovulation induction leads to lowering of both the systolic and diastolic blood pressure 7 as well as the uterine artery resistance index. 8 Similar hCGinduced vascular effects have also been reported for gonadal vessels in other animal species. 9, 10 These observations suggest that hCG may be vasoactive and may possibly contribute to the maternal vascular adaptation of normal pregnancy.
This study is designed to examine the effects of hCG on vascular contractility in vitro.
MATERIALS AND METHODS
The study was approved by the Research and Ethics Committee of the Faculty of Medicine and Health Sciences, UAE University, and conformed with the locally approved Guide for Care and Use of Laboratory Animals.
Female virgin rats of the Wistar strain (230 to 250 g) received a bolus intraperitoneal administration of either 0 IU (control), or 5000 IU of hCG (Pregnyl R ) in 0.5 mL of normal saline water. After 3 h, the systolic blood pressure was measured using the rat tail artery blood pressure recorder (Harvard Instruments, Kent, UK) and the rat was killed by stunning followed by decapitation. A blood sample was obtained at the time of decapitation for estimation of serum ␤hCG level by enzyme immunoassay using the automated Abbott (North Chicago, IL) IMx system.
The descending thoracic aorta was quickly isolated, cleaned of adhering connective tissues, and placed in prewarmed (37°C) physiological salt solution (PSS) of the following composition (mmol/L): NaCl, 119.0; KCl, 4.7; KH 2 PO 4 , 1.2; MgSO 4 , 1.2; NaHCO 3 , 24.9; CaCl 2 , 1.6; and glucose, 11.5. Ring segments approximately 2 mm in length were prepared, carefully mounted between two L-shaped stainless steel holders in 5-mL organ baths containing the PSS at 37°C and bubbled continuously with a gas mixture of 95% O 2 and 5% CO 2 . The upper holder was connected to a Dynamometer UFI (Pioden Controls, Letchworth, UK) isometric transducer coupled to a Lectromed Multitrace 2 recorder (Lectromed, Letchworth, UK) for displaying responses.
Each ring was gently stretched in graded steps to the length on the length-tension curve where there was maximal response to 10 Ϫ5 mol/L phenylephrine. The tension then was regarded as the optimum resting tension. An equilibration period of 90 min was allowed before the commencement of the experiments.
The functional integrity of the endothelium of the rings was established by a demonstration of Ն 42% relaxation to 10 Ϫ7 mol/L acetylcholine in rings precontracted with submaximal concentration (10 Ϫ7 mol/L) of phenylephrine. 11 When indicated, endothelium removal was achieved mechanically by gently rubbing the intimal surface of the rings with a roughened glass rod. 12 The effectiveness of the procedure was confirmed by the subsequent absence of relaxation to 10 Ϫ7 mol/L acetylcholine. 12 Each preparation was used for one protocol only. The described protocol was based on the results of preliminary experiments in which intraperitoneal hCG was administered in doses of 250, 1000, 2500, and 5000 IU for 1, 3, or 16 h. There was concentrationdependent attenuation of responses to phenylephrine, and maximum effects were obtained with administration of 5000 IU of hCG for 3 h. This regimen was used for the test experiments.
Experimental Protocols Contractile responses to phenylephrine. Experiment A This was carried out by cumulative addition of increasing concentrations of phenylephrine (10 Ϫ9 to 10 Ϫ4 mol/L) to the bath containing intact (with endothelium) and de-endothelialized rings.
Experiment B In some of the experiments, aortic rings obtained from untreated rats were incubated with 100,000 IU/L of hCG for 3 h. These were used as test rings for phenylephrine-induced contractions. The controls for these experiments were rings that were equilibrated for similar lengths of time without the addition of hCG.
Experiment C The experiment with phenylephrine was repeated using intact rings preincubated for 30 min with either 10
Ϫ6 mol/L methylene blue, or 10
Experiment D Intact aortic rings obtained from virgin rats treated with 0.5 mg of estradiol in 0.1 mL of propylene glycol/day for 10 days 13 and rats treated with vehicle alone were also contracted with phenylephrine.
Experiment E Contractile response to phenylephrine in calcium-free medium: Intact aortic rings were exposed to calcium-free PSS containing 1.0 mmol/L EGTA for 30 min and then contracted with 10 Ϫ5 mol/L (maximal dose) phenylephrine. The monophasic response is assumed to be proportional to the amount of intracellular calcium released by phenylephrine.
14 Contractile Responses to Angiotensin II This was by cumulative addition of increasing concentrations of angiotensin II (10 Ϫ10 to 10 Ϫ6 mol/L) to the bath containing intact (with endothelium) rings.
Contractile Responses to KCl
This was by cumulative addition of increasing concentrations of KCl (10 to 120 mmol/L) to the bath containing intact (with endothelium) rings. 2 After stabilization, intact rings were contracted to 10 Ϫ5 mol/L phenyleph-rine, and when the contraction was steady, the rings were rinsed with calcium-free PSS, containing 1.0 mmol/L EGTA to remove calcium from the incubating medium. At the end of 15 min in the medium, the tissues were contracted to 10 Ϫ5 mol/L phenylephrine and rinsed repeatedly with the calcium-free PSS containing EGTA (usually twice), until there was no contractile response, implying that the tissue was depleted of phenylephrine-sensitive calcium pools; 5 min later, the medium was changed to calcium-free solution, without EGTA, but containing 10 Ϫ5 mol/L phenylephrine. After a further 15 min, cumulatively increasing concentrations of CaCl 2 (2.5 ϫ 10 Ϫ5 to 2.5 ϫ 10 Ϫ2 mol/L) were added to the bath.
Contractile Responses to CaCl
Solutions Calcium-free PSS was prepared by omission of calcium chloride from the solution.
Drugs Drugs used were phenylephrine hydrochloride, N-monomethyl-l-arginine, methylene blue, angiotensin II, 17 ␤-estradiol (Sigma Chemical, Pook Dorest, UK), indomethacin (Comfortid, Dumex, Copenhagen, Denmark) and human chorionic gonadotrophin (Pregyn, Organon, Oss, Holland). All drugs were prepared fresh with distilled water (except 17␤-estradiol) on the day of study and kept on ice. Concentrations are expressed as final molar concentration (mol/L) in the organ bath. The responses of test and control rings were compared when the data were normalized by expressing data either as milligrams tension/milligrams tissue or as mg tension. There was no significant difference in the conclusions using either method and so the values are presented as milligrams tension (mean Ϯ SEM). In each set of experiments, "n" indicates the number of animals used. For the figures, each contractile response was expressed as a percentage of the mean maximal contractile response of controls to the particular stimulant. Statistical analysis was by two way analysis of variance (ANOVA) for repeated measures. Differences between means were examined by the Student t test. EC 50 values were calculated separately for each experiment. The statistical package used was Prism by Graphpad (San Diego, CA). A P value Ͻ .05 was considered to be significant.
RESULTS
The mean systolic blood pressure and serum concentrations of ␤-hCG in the rat are shown in Table 1 . The mean serum concentration of hCG achieved with intraperitoneal administration of 5,000 IU was less than the peak value normally obtained at 8 to 12 weeks of human gestation (100,000 IU/L) and therefore within physiological range. The systolic blood pressure was significantly reduced at higher concentrations of hCG.
Results of Experimental Protocol
was concentration-dependent contractile response to phenylephrine. The responses of intact rings obtained from hCG-treated animals (n ϭ 8) were significantly (P Ͻ .0001) less than those of rings from control animals (n ϭ 10) (Table 2, Figure 1 ). Similar observations were made when the rings used were de-endothelialized (control n ϭ 8, test n ϭ 8; P ϭ .002; Figure 1 , Table 2 ).
Experiment B The responses of rings incubated with 100,000 IU hCG for 3 h before stimulation (n ϭ 8) were significantly (P Ͻ .001) less than those of controls (n ϭ 10, Table 2 ).
Experiment C The responses of test rings remained significantly (Table 2 ) less than those of similarly treated rings from control animals after incubation with 10 Ϫ4 mol/L L-NMMA (control n ϭ 8, test n ϭ 8, P ϭ .0084, Table 2, Figure 2 ), 10 Ϫ6 mol/L indomethacin (control n ϭ 8, test n ϭ 8, P ϭ .0001, Table 2),  10 Ϫ6 mol/L methylene blue (control n ϭ 9, test n ϭ 8, P ϭ .002, Figure 2 , Table 2 ). There was no significant difference in the EC 50 values of the test and control rings except for rings pretreated with 10 Ϫ4 mol/L L-NMMA and 10 Ϫ6 mol/L methylene blue.
Experiment D The responses of rings obtained from rats treated with 17␤-estradiol (n ϭ 8) were significantly (P Ͻ .05) more than those of control animals. There was no significant difference in the responses of rings from animals treated with the vehicle and those of controls (Figure 3) .
Experiment E In calcium-free medium, the contractile responses of rings from test animals (n ϭ 7) were significantly (P Ͻ .05) less than those from control animals (n ϭ 7, Table 2 ). ( 
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Contractile Responses to Angiotensin II There was concentration-dependent response to the stimulant in all experiments. The mean maximal response of rings obtained from test animals (n ϭ 8) to angiotensin II, was significantly (P Ͻ .0001) less than those of control animals (n ϭ 8, Figure 4 ).
Contractile Responses to KCl
The response to KCl of test rings (n ϭ 8) was also less (P Ͻ .05) than those of controls (n ϭ 8, Figure 5 ).
Contractile Responses to CaCl 2
Similarly, the maximal contractile response to CaCl 2 of test rings (n ϭ 7) was significantly less (P Ͻ .01) than those of controls (n ϭ 7, Figure 6 ). There was no significant difference between the mean EC 50 values for tests and controls.
DISCUSSION
Human chorionic gonadotrophin is a glycoprotein produced in large amounts by the trophoblast. Although it is generally accepted that hCG plays a luteotrophic role in early pregnancy, its functions subsequently remain largely unknown.
Administration of hCG resulted in increased blood flow to the uterus and testes 9, 10, 15 in the pig and the rat, and ovulatory doses of hCG caused significant decreases in the resistance index of human uterine arteries 8 as well as reduction of both diastolic and systolic blood pressures. 7 Receptors for hCG/LH have been localized in the vascular smooth muscle and endothelial cells of these vessels. 8 Thus, it is possible that hCG may have vascular smooth muscle regulatory functions and, if so, contribute to the vasorelaxation of normal pregnancy.
Our results showed that intraperitoneal administration of hCG resulted in significant attenuation of the systolic blood pressure in rats. The contractile responses to phenylephrine of isolated aortic rings from hCG-treated animals and of rings from untreated animals incubated with 100,000 IU/L of hCG in the bath were also significantly depressed.
There is probably a link between the lowering of blood pressure and the attenuation of vascular reactivity by hCG treatment. The dose of hCG used for ex vivo incubation is the mean peak serum concentration of the hormone in normal human pregnancy between 8 and 10 weeks gestation.
Vascular reactivity is modulated by the endothelium through the production of vasodilators such as nitric oxide (endothelium-derived relaxing factor), prostacyclin, endothelium-derived hyperpolarizing factor, and vasoconstrictors such as endothelium-derived constricting factor and thromboxane. 16 In normal pregnancy, there is an endothelium-dependent attenuation of vascular reactivity that involves enhanced production of these vasodilators. 2, 4, 17, 18 However, the contraction attenuating effect of hCG is unlikely to be the result of increased production of nitric oxide, because the application of L-NMMA in this study (to block nitric oxide synthase) did not normalize the contractile responses to phenylephrine. Pretreatment of the rings with methylene blue (which inhibits the guanylate cyclase) also did not normalize the responses, suggesting that hCG did not stimulate nitric oxide synthase or guanylate cyclase. Similarly, hCG treatment probably did not stimulate production of vasodilator prostaglandin, as pretreatment with indomethacin to block the cyclooxygenase enzyme failed to normalize the responses to phenylephrine. Nevertheless, a previous study had reported dosedependent hCG stimulation of immunoreactive prostacyclin synthase and inhibition of thromboxane A 2 synthase activity by human myometrial arteries. 8 The different observations may be explained by differences in tissue characteristics, because there is no increase in production of prostaglandins associated with the attenuation of vascular responses to phenylephrine in the pregnant rat aorta. 2, 19 The responses of rings from hCG-treated animals to phenylephrine were not normalized by deendothelialization, reinforcing the view that endothelium-derived relaxants are not likely to be involved in the attenuation of contractile responses to phenylephrine.
It is possible that the effects of hCG were mediated through release of endogenous estrogen, as the animals used were not ovariectomized. However, aortic rings from animals given chronic administration of estrogen showed enhanced, rather than attenuated, responses to phenylephrine. This effect of estrogen on vascular reactivity is consistent with results from other studies, which showed that the blood pressure 13 and ex vivo reactivity to noradrenaline and phenylephrine 20, 21 of aortic rings from normotensive and ovariectomized 21 rats were enhanced by chronic administration of estrogen. The mechanism remains unresolved. 
